Stocks to sell

MicroVision (NASDAQ:MVIS) is a company seeking to commercialize light detection and ranging (lidar) technology. The company has been in business since the 1990s and has little to show for it. MVIS stock peaked around $500/share during the 2000 dot-com bubble, and trades at a tiny fraction of that today. Source: temp-64GTX/Shutterstock.com That said, MicroVision has

ContextLogic (NASDAQ:WISH) has been hammered from its highs, but WISH stock has shown promise lately. On Oct. 19, it rallied 5.5% and on Oct. 20, it followed it up with a rally of 14%. Granted, the stock remains more than 80% below its all-time high from earlier this year. However, it’s making strides at recovering

Cloudflare (NYSE:NET) stock keeps pushing higher, even though its valuation is in nosebleed territory. I want to recommend investors buy NET stock, but I can’t do that in good conscience. In fact, at this point, the only thing I can do is point out how incredibly overvalued it seems to be, even as it continues

Cloudflare (NYSE:NET) stock has performed extremely well in 2021. As of Oct. 20, it’s up 130%, opening at $175.80. With this in mind, many investors think that there are only two scenarios for NET stock. Either this momentum will continue, sending prices higher, or more prudent, conservative investors and traders will wait for a dip

Microvision (NASDAQ:MVIS) stock became a meme stock this year because of self-driving cars. Source: Andrey_Popov/ShutterStock.com There’s an assumption that electrics and self-driving are part of the same revolution. Blame Tesla (NASDAQ:TSLA), which has been teasing autonomy along, with some people dying  because it can’t meet the promise. Lidar is the technology that’s supposed to make

UiPath (NYSE:PATH) is a $25.79 billion technology stock that is draining out cash and seems to be having trouble with top-line growth. This means that the company may have trouble maintaining this high valuation. As a result, PATH stock is likely to keep falling. Source: dennizn / Shutterstock.com In fact, from its peak of $85.00

Olaplex (NASDAQ:OLPX) just had a unique IPO on Sept. 30. The IPO price of $21 resulted in a huge capital raise of $1.78 billion from the sale of OLPX stock. However, as opposed to almost every other IPO there is, this capital raise is going straight to the pockets of the existing private equity owners,

Wish.com parent company ContextLogic (NASDAQ:WISH) stock has been a disaster since its initial public offering. Source: sdx15 / Shutterstock.com Wish went public at an IPO price of $24 in December 2020. The stock rallied as high as $32.85 in February during the Reddit WallStreetBets trading fury. Since then, the stock has dropped like a rock.

Just over a year ago, Hyliion (NYSE:HYLN) was one of the hottest electric vehicle special-purpose acquisition company (SPAC) plays out there. Just before its “de-SPACing,” excitement over this maker of electric trucks and powertrains briefly sent HYLN stock to prices over $50 per share. Source: Shutterstock Flash forward back to now, and where are shares changing

With shares moving up following the acquisition of Nanotech, is it time to buy Meta Materials (NASDAQ:MMAT) stock, ahead of its revenues taking off? Not so fast. It’s still down big from the high prices it hit when it first appeared on the radar of meme stock investors. But at $5.31 per share, this smart

OpenDoor (NASDAQ:OPEN) stock is the kind of name I’ve learned to avoid. Source: PREMIO STOCK/Shutterstock.com Over my years of investing, I’ve learned–in some cases, the hard way — that buying stocks on weakness is really the best and easiest way to make money in the market. Conversely, buying risky names that are riding positive momentum

Tech stocks are hot property in 2021 but that is not the case with Intel (NASDAQ:INTC) stock. Source: Pavel Kapysh / Shutterstock.com The stock started diving a long time ago and has continued to do so for the past few months. INTC stock managed to hit an all-time high of $68 in January 2020 and

A few months ago, the Federal Reserve was talking about “transitory” inflation. The governors at the Fed meant that while inflation was rising swiftly, it wasn’t going to last. But inflation kept rising at a brisk clip and the Fed started to be less sanguine about the transitory nature of inflation. It hedged by telling

Ocugen (NASDAQ:OCGN) is a small biotech firm. For years, it tried unsuccessfully to commercialize therapies for eye diseases. However, in 2020, it ended a Phase 3 trial on that front and pivoted to Covid-19. Its first effort in that regard, Covid-19 testing, totally failed to take off. The company is nothing if not persistent, however,

I fully understand why it’s very tempting to buy Alibaba (NASDAQ:BABA) stock at this point. The company’s shares have tumbled a great deal in the last six months, yet the company remains one of the biggest and most successful e-commerce players on the planet, and its cloud business is still growing rapidly. Source: BigTunaOnline /

Israeli online freelancer platform Fiverr (NYSE:FVRR) is the definition of a mixed bag. The company has some key strengths that are balanced out by some equally important weaknesses. I typically find it’s best to avoid companies like this unless their shares are trading at a very attractive valuation. In the case of FVRR stock, that

ContextLogic (NASDAQ:WISH) stock has kept falling this year, especially after its disastrous second-quarter results. WISH stock reached a recent peak on June 28 at $14.40 and has slumped to $5.18 as of Oct. 13. Source: sdx15 / Shutterstock.com In fact, as of Oct. 13, the stock is down more than 71.6% from $18.24 year-to-date. Investors

Zoom Video Communications (NASDAQ:ZM) was one of the prime beneficiaries of the coronavirus pandemic. It closed out 2020 with a colossal run rate of $3.5 million in revenues. However, judging from recent results, its top- and bottom-line growth are slowing as we inch closer to a post-pandemic reality. Moreover, ZM stock is incredibly overvalued based

There are a few reasons why investors piled into Clover Health (NASDAQ:CLOV) stock this year. It was a popular SPAC stock headed by the charismatic Chamath Palihapitaya. And its Jan. 8 merger with Social Capital Hedosophia, a SPAC, made many investors aware of the company. Clover is a Medicare insurance services provider.  Source: Shutterstock But

When you have nearly 3 billion monthly active users, some things are bound to go wrong. As the adage goes, you can please some of the people all of the time, you can please all of the people some of the time, but you can’t please all of the people all of the time. That